Clinical Trial Update: Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM) [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing contrast-enhanced spectral mammography to evaluate neoadjuvant chemotherapy response in breast cancer has terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 4 | Status: TERMINATED | Results posted: 2023-10-12